竞争的内源RNAs (ceRNAs) 和对癌症治疗的耐药性
Kenneth K W To1, Hang Zhang1, William C Cho2
1School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR 999077, China.
Cancer drug resistance (Alhambra, Calif.)
|October 15, 2024
概括
竞争的内源RNA (ceRNA) 网络调节生物过程,并与癌症药物耐药性有关. ceRNAs的失调有助于化疗失败,突出了它们作为预后生物标志物的潜力.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 生物化学 生化学
背景情况:
- 竞争的内源RNAs (ceRNAs) 是共享微RNA响应元素 (MREs) 的RNA转录.
- 微RNAs (miRNAs) 通过结合MREs在目标信使RNAs (mRNAs) 上来调节基因表达.
- ceRNAs,包括mRNAs,圆形RNAs (circRNAs),长非编码RNAs (lncRNAs) 和伪基因,可以争夺miRNAs,形成ceRNA网络.
研究的目的:
- 审查关于癌症药物耐药性ceRNA失调的最新研究.
- 探索ceRNA网络在各种癌症类型和药物类别的化疗耐药性中的作用.
- 讨论ceRNAs作为预后生物标志物的潜力,用于预测化疗反应.
主要方法:
- 关于ceRNA网络和癌症药物耐药性的最近研究的文献综述.
- 在获得的化疗耐药性中,基于ceRNA失调的机制的分析.
- 关于ceRNA交叉在瘤学的临床影响的证据综合.
主要成果:
- ceRNA网络在调节生物过程中发挥着重要作用.
- 越来越多的CeRNA交叉调节失调被认为是癌症化疗耐药性的贡献者.
- ceRNAs显示出作为预测生物标志物对患者对癌症治疗反应的承诺.
结论:
- ceRNA网络对生物调节至关重要,并与癌症药物耐药性有关.
- 了解ceRNA失调提供了关于化疗失败机制的见解.
- 对计算式ceRNA网络进行进一步的实验验证对于临床翻译至关重要.
更多相关视频
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
165
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
